Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Monogram Technologies Inc. - Common Stock (NQ: MGRM )

2.940 +0.080 (+2.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60,954
Open 2.840
Bid (Size) 2.900 (2)
Ask (Size) 2.930 (35)
Prev. Close 2.860
Today's Range 2.830 - 3.060
52wk Range 1.820 - 4.205
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community
Via ACCESS Newswire
These stocks have an unusual volume in today's session
Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill

Performance

YTD
+23.53%
+23.53%
1 Month
-3.61%
-3.61%
3 Month
+4.11%
+4.11%
6 Month
+23.01%
+23.01%
1 Year
+26.18%
+26.18%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
Via ACCESS Newswire
Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India
Via ACCESS Newswire
Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDA
Via ACCESSWIRE
Monogram Technologies Reports Third Quarter 2024 Financial Results
Via ACCESSWIRE
EXCLUSIVE: FDA Approves Monogram Technologies' mBôs TKA System For Knee Surgery
Via Benzinga
Exposures Product Safety
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results
Via ACCESS Newswire
Monogram Technologies Reports Full Year 2024 Financial Results
Via ACCESS Newswire
Monogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025
Via ACCESS Newswire
Monogram Technologies to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, March 12, 2025 at 4:30 p.m. Eastern Time
Via ACCESS Newswire
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
Via ACCESSWIRE
CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
Via ACCESSWIRE
Monogram Technologies Receives FDA Response for mBôs TKA System
Via ACCESSWIRE
Earnings Scheduled For March 12, 2025
Via Benzinga
How Monogram’s (NASDAQ: MGRM) Dynamic Approach To Robotics Could Help Reshape the Future Of Orthopedics
Via News Direct
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million
Via ACCESSWIRE
Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
Via ACCESSWIRE
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
Via ACCESSWIRE
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
Via ACCESSWIRE
Monogram Technologies Announces Preferred Stock Dividends
Via ACCESSWIRE
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
Via ACCESSWIRE
Monogram Orthopedics (NASDAQ: MGRM) Readies Commercialization Of Next-Gen Surgical Robot
Via News Direct
Monogram Orthopedics (NASDAQ: MGRM) Lands Key Clinical Trial Partnership With India’s Leading Orthopedic Hospital Group To Advance Its Surgical Robot Tech
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.